Circular RNAs as Biomarkers in Breast Cancer Diagnosis, Prognosis, Molecular Types, Metastasis and Drug Resistance
Technology in Cancer Research & Treatment · 2025
DOI: 10.1177/15330338251328500 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Technology in Cancer Research & Treatment, 2025. Verfasst von Li-Xin Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, General Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, People's Republic of China. Hauptthemen laut MEDLINE: Breast Neoplasms, RNA, Circular, Biomarkers, Tumor, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Natural Science Foundation of Shandong Province, Special Funds for Scientific Research on Breast Diseases of Shandong Medical Association.
Abstract (Originalsprache)
Breast cancer is one of the leading causes of cancer-related deaths in women worldwide. Circular RNAs (circRNAs), a novel class of endogenous noncoding RNA with a covalently closed continuous loop that lacks the 5′-cap structure and the 3′-poly A tail, are more stable than linear RNAs and less susceptible to degradation by nucleases. CircRNAs are widespread in multiple mammalian genomes and have been detected in various tissues, cells and body fluids. Increasing evidence shows that abnormal expression of circRNAs is involved in the development of a variety of diseases, including breast cancer. Numerous studies have explored the potential of circRNAs as biomarkers in various malignant tumors. In this review, we aim to provide a comprehensive overview of the latest advances in circRNAs as promising biomarkers in the early diagnosis, prognosis, molecular type, metastasis and drug resistance of breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Breast Surgery, General Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, People's Republic of China.
- Department of General Surgery, Binzhou Second People's Hospital, Binzhou, Shandong, People's Republic of China.
- Department of Breast Thyroid Surgery, Jinan Shizhong District People's Hospital, Jinan, Shandong, People's Republic of China.
- Department of Pediatric Surgery, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, People's Republic of China.
ORCID-Profile: Yun Hao, Ya-Wen Wang
Förderung
- Natural Science Foundation of Shandong Province
- Special Funds for Scientific Research on Breast Diseases of Shandong Medical Association
Zitieren
APA
Li, L. X., Hao, Y., Dong, L., Qiao, Z. Q., Yang, S. C., Chen, Y. D., Zhang, K., & Wang, Y. W. (2025). Circular RNAs as Biomarkers in Breast Cancer Diagnosis, Prognosis, Molecular Types, Metastasis and Drug Resistance. Technology in Cancer Research & Treatment. https://doi.org/10.1177/15330338251328500
Vancouver
Li LX, Hao Y, Dong L, Qiao ZQ, Yang SC, Chen YD, et al. Circular RNAs as Biomarkers in Breast Cancer Diagnosis, Prognosis, Molecular Types, Metastasis and Drug Resistance. Technology in Cancer Research & Treatment. 2025. doi:10.1177/15330338251328500
BibTeX
@article{Li2025,
author = {Li, Li-Xin and Hao, Yun and Dong, Lei and Qiao, Zhong-Qi and Yang, Shun-Chao and Chen, Yan-Duo and Zhang, Kai and Wang, Ya-Wen},
title = {Circular RNAs as Biomarkers in Breast Cancer Diagnosis, Prognosis, Molecular Types, Metastasis and Drug Resistance},
journal = {Technology in Cancer Research & Treatment},
year = {2025},
doi = {10.1177/15330338251328500}
}
EUVIMED